MENU
+Compare
SHPMY
Stock ticker: OTC
AS OF
Jul 25 closing price
Price
$8.00
Change
+$0.52 (+6.95%)
Capitalization
9.5B

SHPMY Shanghai Pharmaceuticals Holdings Co., Ltd. Forecast, Technical & Fundamental Analysis

Shanghai Pharmaceuticals is the second-largest medical distributor in China by revenue... Show more

SHPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SHPMY with price predictions
Jul 25, 2025

SHPMY in upward trend: 10-day moving average crossed above 50-day moving average on June 24, 2025

The 10-day moving average for SHPMY crossed bullishly above the 50-day moving average on June 24, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

SHPMY moved above its 50-day moving average on June 24, 2025 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 70 cases where SHPMY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

SHPMY broke above its upper Bollinger Band on July 25, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SHPMY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.716) is normal, around the industry mean (7.892). P/E Ratio (8.389) is within average values for comparable stocks, (29.460). Projected Growth (PEG Ratio) (2.467) is also within normal values, averaging (4.521). Dividend Yield (0.045) settles around the average of (0.032) among similar stocks. P/S Ratio (0.204) is also within normal values, averaging (35.215).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SHPMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.

View a ticker or compare two or three
SHPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

SHPMY is expected to pay dividends on September 09, 2025

Shanghai Pharmaceuticals Holdings Co., Ltd. SHPMY Stock Dividends
A dividend of $0.20 per share will be paid with a record date of September 09, 2025, and an ex-dividend date of July 17, 2025. The last dividend of $0.06 was paid on November 12. Read more...
A.I. Advisor
published General Information

General Information

Industry MedicalDistributors

Profile
Fundamentals
Details
Industry
N/A
Address
No. 200 Taicang Road
Phone
+86 2163730908
Employees
47877
Web
https://www.sphchina.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SOVF30.420.24
+0.79%
Sovereign's Capital Flourish Fund
VFQY147.840.58
+0.39%
Vanguard US Quality Factor ETF
DIEM30.86-0.12
-0.37%
Franklin Emerging Mkt Core Div TltIdxETF
BABO15.41-0.06
-0.39%
YieldMax BABA Option Income Strategy ETF
MLPX60.59-0.53
-0.87%
Global X MLP & Energy Infrastructure ETF

SHPMY and Stocks

Correlation & Price change

A.I.dvisor tells us that SHPMY and NSVGF have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHPMY and NSVGF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHPMY
1D Price
Change %
SHPMY100%
+9.93%
NSVGF - SHPMY
14%
Poorly correlated
N/A
COSM - SHPMY
12%
Poorly correlated
+23.16%
SHTDF - SHPMY
12%
Poorly correlated
N/A
ZYXI - SHPMY
7%
Poorly correlated
+1.20%
SHPMF - SHPMY
7%
Poorly correlated
N/A
More